CoChat

GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrier

Boado, Ruben J., Zhang, Yun, Zhang, Yufeng, Wang, Yuntao, Pardridge, William M. · 2008 · Biotechnology and Bioengineering
Cited by 96

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Glial‐derived neurotrophic factor (GDNF) is a neurotrophin that could be developed as a neurotherapeutic for Parkinson's disease, stroke, and motor neuron disease. However, GDNF does not cross the blood–brain barrier (BBB). Human GDNF was re‐engineered by fusion of the mature GDNF protein to the carboxyl terminus of the chimeric monoclonal antibody (MAb) to the human insulin receptor (HIR). The HIRMAb‐GDNF fusion protein is bi‐functional, and both binds the HIR, to trigger receptor‐mediated transport across the BBB, and binds the GDNF receptor (GFR)‐α1, to activate GDNF neuroprotection pathways behind the BBB. COS cells were dual transfected with the heavy chain (HC) and light chain fusion protein expression plasmids, and the HC of the fusion protein was immunoreactive with antibodies to both human IgG and GDNF. The HIRMAb‐GDNF fusion protein bound with high affinity to the extracellular domain of both the HIR, ED 50 = 0.87 ± 0.13 nM, and the GFRα1, ED 50 = 1.68 ± 0.17 nM. The HIRMAb‐GDNF fusion protein activated luciferase gene expression in human neural SK‐N‐MC cells dual transfected with the c‐ret kinase and a luciferase reporter gene under the influence of the rat tyrosine hydroxylase promoter, and the ED 50, 1.68 ± 0.45 nM, was identical to the ED 50 in the GFRα1 binding assay. The fusion protein was active in vivo in a rat middle cerebral artery occlusion model, where the stroke volume was reduced 77% (P < 0.001). In conclusion, these studies describe the re‐engineering of GDNF, to make this neurotrophin transportable across the human BBB. Biotechnol. Bioeng. 2008;100: 387–396. © 2007 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bit.21764

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 96

Metadata

Authors
Boado, R. J., Zhang, Y., Zhang, Y., Wang, Y., & Pardridge, W. M.
Venue
Biotechnology and Bioengineering
Publisher
Wiley
Published
2007-12-13
Volume
100
Issue
2
Pages
387-396
ISSN
  • 0006-3592 (ISSN-L)
  • 1097-0290
OpenAlex
W2083284350
Cited by
96
References
2
FWCI
3.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrier. https://app.cochat.ai/papers/10.1002/bit.21764
The paper
Boado, R. J., Zhang, Y., Zhang, Y., Wang, Y., & Pardridge, W. M. (2008). GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrier. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.21764

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.